1. 129: Stereotactic ablative body radiotherapy (SABR) for early stage non-small cell lung cancer (NSCLC) at a tertiary referral centre results of the first year of treatment at Birmingham. (January 2015) Authors: Stevenson, R.; Price, L.; Webster, G.; Brennan, M.; Stange, D.; Wingate, E.; Biard, K.; Ghafoor, Q. Journal: Lung cancer Issue: Volume 87(2015)Supplement 1 Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Durvalumab for stage III non-small cell lung cancer (NSCLC): early access programme (EAP) in University Hospitals Birmingham (UHB), UK. (January 2020) Authors: Powell, R.; Kussaibati, R.; Page, E.; Wingate, E.; Khan, A.; Stevenson, R.; Ghafoor, Q.; Baijal, S. Journal: Lung cancer Issue: Volume 139(2020)Supplement 1 Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Quality of Life and Symptoms in Patients Undergoing Stereotactic Ablative Body Radiotherapy (SABR) for Early Stage Lung Cancer. Issue 6 (June 2018) Authors: Gray, C.; Wingate, E.; Ghafoor, Q. Journal: Clinical oncology Issue: Volume 30:Issue 6(2018) Page Start: e56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SP-0152 Safely regularising breathing motion and prolonging single breath-holds for radiotherapy with a mechanical ventilator. (August 2021) Authors: Parveen, S.; Parkes, M.; Wingate, E.; Shingler, B.; Green, S.; Ghafoor, Q. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗